uniQure Presents New Data Demonstrating Clinical Benefit in Hemophilia B Patients with Pre-Existing Anti-AAV5 Neutralizing Antibodies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| UNIQURE (NASDAQ: QURE) | Delayed: 22.70 -0.36 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.06 | 52 Week High | $22.79 | |||
| Open | $22.96 | 52 Week Low | $6.63 | |||
| Day High | $23.30 | P/E | N/A | |||
| Day Low | $22.64 | EPS | $0.00 | |||
| Volume | 659,686 | |||||
